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Abstract
Germline mutations in the basic helix-loop-helix transcription factor 4 (TCF4) cause 
the Pitt–Hopkins syndrome (PTHS), a developmental disorder with severe intellec-
tual disability. Here, we report findings from a new mouse model with a central nerv-
ous system-specific truncation of Tcf4 leading to severe phenotypic abnormalities. 
Furthermore, it allows the study of a complete TCF4 knockout in adult mice, circum-
venting early postnatal lethality of previously published mouse models. Our data sug-
gest that a TCF4 truncation results in an impaired hippocampal architecture affecting 
both the dentate gyrus as well as the cornu ammonis. In the cerebral cortex, loss 
of TCF4 generates a severe differentiation delay of neural precursors. Furthermore, 
neuronal morphology was critically affected with shortened apical dendrites and 
significantly increased branching of dendrites. Our data provide novel information 
about the role of Tcf4 in brain development and may help to understand the mecha-
nisms leading to intellectual deficits observed in patients suffering from PTHS.
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1 |  INTRODUCTION
Heterozygous germline mutations of the transcription factor 4 
(TCF4, also known as SEF2, ITF2, E2-2, ME2 and others) lead 
to the Pitt–Hopkins syndrome (PTHS), a congenital autism 
spectrum disorder associated with intellectual disability (ID). 
ID is a symptom of almost all developmental disorders and, 
although a lot of research was done, the molecular mechanisms 
of ID in most congenital syndromes remain widely unknown.
PTHS patients present with a number of different symp-
toms including ID, a global developmental delay, certain 
characteristic facial features, short stature and microceph-
aly (Sweatt, 2013). PTHS was first described in 1978 (Pitt 
& Hopkins, 1978) and in 2007, germline mutations in the 
gene encoding TCF4 were identified as the cause of the syn-
drome (Amiel et al., 2007; Brockschmidt et al., 2007; Zweier 
et al., 2007). Besides, a tumour-suppressive role of TCF4 in 
medulloblastoma was described, highlighting the importance 
of the transcription factor (TF) in developmental processes 
(Hellwig et al., 2019).
TCF4 is a member of the family of basic helix-loop-helix 
(bHLH) TFs. These proteins have a DNA-binding domain 
and form homo- or heterodimers to regulate gene expres-
sion. The dimers of TFs can exert different functions de-
pending on their dimerization partners (Jones, 2004). Within 
the family of bHLH TFs, TCF4 belongs to the subgroup of 
E-proteins, which share the recognition of the pseudo-pal-
indromic Ephrussi box (E-box) DNA element (Massari & 
Murre, 2000). TCF4 can dimerize with numerous other TFs, 
and interactions of TCF4 with ATHO1 (MATH1), HASH1 
and NEUROD1 have been described in the brain (Flora, 
Garcia, Thaller, & Zoghbi, 2007; Navarrete et al., 2013). 
Mutations in PTHS patients affect different domains of the 
protein; however, the bHLH domain is described as a mu-
tational hotspot (Whalen et al., 2012). Consequences of the 
mutations range from decreased binding ability to DNA or 
its dimerization partner to a loss-of-function or even a domi-
nant-negative effect of the mutated protein (Sepp, Pruunsild, 
& Timmusk, 2012). In this regard, the authors like to em-
phasize not to confuse the TCF4 (Gene ID:6925) discussed 
in this manuscript with the transcription factor 7-like 2 gene 
(Gene ID:6934, official gene symbol TCF7L2). The latter is 
often referred to as T-cell factor 4 which is commonly but 
mistakenly abbreviated as TCF4.
To understand TCF4 functions and PTHS pathobiology, 
different mouse models have been developed. Conventional 
homozygous deletion is lethal shortly after birth (Flora et 
al., 2007; Zhuang, Cheng, & Weintraub, 1996), and so 
previous work attempting to understand the function of 
TCF4 in brain development used heterozygous knockout 
mouse models, mimicking the situation in PTHS patients. 
It has been shown that these animals recapitulate differ-
ent aspects of the human syndrome, such as an overall 
developmental delay, problems in social interactions and 
vocal articulation (Kennedy et al., 2016; Rannals, Page, 
et al., 2016b; Thaxton et al., 2018). Also, Jung et al. de-
scribed the importance of TCF4 in the context of hippo-
campal and cortical neuron development and plasticity 
(Jung et al., 2018). That TCF4 might play a critical part in 
keeping up neuronal connectivity and excitatory-inhibitory 
balance was well described before by Sepp et al. (2017). In 
2019, Li et al. used conventional knockout mice to study 
the consequences of a TCF4 deletion in the brain (Li et 
al., 2019). Newborn homozygous as well as newborn and 
adult heterozygous knockout mice were employed to de-
scribe a role of TCF4 in neural differentiation and migra-
tion, but their mouse model did not allow the study of a 
complete deletion of TCF4 in adult postnatal animals (Li et 
al., 2019). They also show abnormal dendrite and synapse 
formation in their mouse model, which was also reported 
by D'Rozario et al. (2016). It is therefore consequent that 
TCF4 is not only discussed in the context of PTHS, but 
has also been associated with different neurodevelopmen-
tal disorders such as ID, the autism spectrum disorder and 
schizophrenia (Brzozka, Radyushkin, Wichert, Ehrenreich, 
& Rossner, 2010; Forrest et al., 2018; Hasi et al., 2011; 
Moen et al., 2017; O'Donnell et al., 2010).
In this study, we used a central nervous system (CNS)-
specific TCF4 knockout mouse model (hGFAP-cre::Tcf4Fl/Fl), 
which allowed us to investigate an organ-specific homozy-
gous knockout of TCF4 at different ages including adult an-
imals in order to specifically identify structures affected by 
the knockout. Our data suggest a function of TCF4 in the 
formation of hippocampal and cortical architecture, in the 
differentiation of neuronal precursors, and in neuronal mor-
phology in both, developing and adult mice. These findings 
complement previous studies on TCF4 and help to further 
understand its role in the pathophysiology of PTHS and in 
brain development in general.
2 |  MATERIAL AND METHODS
2.1 | Mice
hGFAP-cre mice (Brenner, Kisseberth, Su, Besnard, & 
Messing, 1994; Zhuo et al., 2001) were purchased from The 
Jackson Laboratory. Tcf4Fl/Fl mice (Bergqvist et al., 2000) 
have been obtained from Dan Holmberg. Genotyping was 
performed with genomic DNA from ear biopsies with primer 
pairs described before (Bergqvist et al., 2000; Zhuo et al., 
2001). Mice were bred on a C57BL/6 background and kept 
on a 12 hr dark/light cycle; water and food were available 
ad libitum. Animals of both sexes were used for the experi-
ments. All experimental procedures were approved by the 
City of Hamburg (Reference: 113/16).
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2.2 | Immunohistochemistry and 
quantification
Animals were decapitated under anaesthesia, and the brains 
were dissected. After fixating the brain tissues in 4% para-
formaldehyde/PBS over night at room temperature, the tis-
sue was dehydrated, embedded in paraffin and sectioned at 
4 µm. Immunohistochemistry was subsequently performed 
using standard protocols with the following primary anti-
bodies: PROX1 (ab199359, abcam, 1:500), SOX2 (ab97959, 
abcam, 1:200), CRE (PRB-106P, Biolegend, 1:3,000), 
KI67 (ab15580, abcam, 1:100), NEUN (MAB377, Merck 
Millipore, 1:25), CTIP2 (ab18465, abcam, 1:100), RELN 
(MAB5364, Merck Millipore, 1:500) and CUX1 (11733-
1-AP, Proteintech, 1:200). Detection was performed using 
the SuperVision 2 HRP Kit (DCS Diagnostics) according 
to the standard protocol provided by the manufacturer. 
Cell nuclei were counterstained using haematoxylin. For 
quantifications, up to five representative pictures of the 
indicated region of three mice per genotype were taken 
and quantified. Image J 1.48a (Fiji)(NIH) was used by a 
blinded observer for quantification of thickness, distance 
and cell counting.
2.3 | Golgi–Cox staining and quantification
Golgi–Cox staining of adult mouse brains was performed 
using the FD Rapid GolgiStain Kit (FD NeuroTechnologies, 
Inc.) according to manufacturer's instructions. Briefly, freshly 
dissected brains were impregnated with a premade solution 
of mercuric chloride, potassium dichromate and potassium 
chromate for 1 week, cut in 200 µm slices with a vibrating 
blade microtome (Leica VT 1000S), and the impregnation 
was visualized with a solution provided by the manufac-
turer. For quantification of dendrite length and the number 
of branches, 10 representative pictures per mouse brain were 
taken and three mice per genotype were used.
2.4 | RNA-sequencing
After isolation of total RNA, the RNA integrity was ana-
lysed with the RNA 6,000 Nano Chip on an Agilent 2100 
Bioanalyzer (Agilent Technologies). From total RNA, 
mRNA was extracted using the NEBNext Poly(A) mRNA 
Magnetic Isolation module (New England Biolabs) and 
RNA-Seq libraries were generated using the NEXTFLEX 
Rapid Directional qRNA-Seq Kit (Bioo Scientific) as per 
the manufacturer's recommendations. Concentrations of 
all samples were measured with a Qubit 2.0 Fluorometer 
(Thermo Fisher Scientific), and fragment lengths distribu-
tion of the final libraries was analysed with the DNA High 
Sensitivity Chip on an Agilent 2100 Bioanalyzer (Agilent 
Technologies). All samples were normalized to 2nM and 
pooled equimolar. The library pool was sequenced on the 
NextSeq500 (Illumina) with 1 × 75 bp, with 16.5 to 18.2 
mio reads per sample.
2.5 | RNA-sequencing analysis
Gene abundance was quantified using salmon (v0.12.0) 
(Patro, Duggal, Love, Irizarry, & Kingsford, 2017) and 
mouse gene annotations from ENSEMBL (version 97) for 
GRCm38 genome assembly, and imported using R package 
tximport (Soneson, Love, & Robinson, 2015). Counts nor-
malization and differential gene expression analysis were 
performed using DESeq2 package which automatically 
filters for low-expression genes and differentiates them 
for noise (Love, Huber, & Anders, 2014). Null variance 
of Wald test statistic output by DESeq2 was re-estimated 
using R package fdrtool (Strimmer, 2008) to calculate p-
values (and adjusted using Benjamini-Hochburg method) 
for the final list of differentially expressed gene (DEG). An 
FDR (BH-adjusted p-values) <.1 was used a criteria for the 
final DE gene list. Gene ontology enrichment analysis was 
performed on the obtained gene list using topGO (Alexa 
& Rahnenfuhrer, 2019). Ten non-DE genes having simi-
lar mean expression level per each DE gene were selected 
for enrichment analysis as background using R package 
genefilter (Bourgon & Huber). GO plots for enrichment of 
biological process were plotted using R package cluster-
Profiler (Yu, Wang, Han, & He, 2012).
2.6 | Statistics
All data presented are mean  ±  SEM (standard error of the 
mean), and each data point represents an individual animal. 
Statistical analyses were done using the Prism 7 software 
(Graph Pad). p values ≤  .05 were considered significant 
(*p ≤ .05, **p ≤ .01, ***p ≤ .001, ****p ≤ .0001). The un-
paired t test (two-tailed) was applied to compare the means 
of two groups. In order to compare percentages, values were 
arcsin transformed for statistical analysis.
3 |  RESULTS
3.1 | CNS-specific deletion of TCF4 results 
in microcephaly
In this study, we employed a CNS-specific TCF4 knockout 
mouse model to study the protein function of TCF4. The CNS 
specificity was achieved with an inducible Cre/LoxP system, 
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in which the Cre recombinase is driven by the human glial 
fibrillary acidic protein (hGFAP) promoter and therefore starts 
being expressed on embryonic day E 13 (Zhuo et al., 2001). 
HGFAP expression is mainly found in astrocytes of adult 
brains, but previous studies by Schüller et al. and Spassky 
et al. demonstrated that also radial glia cells, which gener-
ate most cerebellar cell types, including (cerebellar) granule 
neuron precursors, interneurons, forebrain stem cells and as-
trocytes, express the Cre recombinase under the hGFAP pro-
moter (Schüller et al., 2008; Spassky et al., 2008). Thereby, 
recombination leads to an effect in most, but not all cells of 
the adult nervous system. The Cre-driven recombination re-
sults in a truncated TCF4 protein, which lacks the protein do-
mains transcribed from the exons 18, 19 and parts of exon 20 
(Figure 1a). The translated protein misses the bHLH domain, 
which results in an abolished DNA-binding ability of the TF. 
Previous work on TCF4 showed that the bHLH domain is a 
mutational hotspot in PTHS patients (Whalen et al., 2012), 
emphasizing the previously established essential function 
of this protein domain (Murre, McCaw, & Baltimore, 1989; 
Voronova & Baltimore, 1990). The successful recombination 
was ensured by PCR: as expected, bands for the recombined 
TCF4 allele were visible in hGFAP-cre::Tcf4Fl/wt and hGFAP-
cre::Tcf4Fl/Fl but not in control mice carrying only the hGFAP-
cre transgene (Figure 1b).
We generated control mice carrying only the hGFAP-cre 
transgene, mice carrying a recombined Tcf4 gene on one al-
lele (hGFAP-cre::Tcf4Fl/wt) and mice carrying the truncating 
mutation homozygously (hGFAP-cre::Tcf4Fl/Fl), henceforth 
referred to as mutant mice. With respect to the overall brain 
morphology, mice carrying the heterozygous mutation were 
indistinguishable from their control littermates (Figure 1c). 
However, in mice with homozygous Tcf4 mutations, the 
brain appears smaller, mainly due to a considerably dimin-
ished telencephalon (Figure 1c). To quantify this observa-
tion, we weighed the freshly dissected brains of hGFAP-cre, 
hGFAP-cre::Tcf4Fl/wt and hGFAP-cre::Tcf4Fl/Fl mice at three 
different time points during postnatal development (Figure 
1d). In line with the visual impressions, hGFAP-cre::Tcf4Fl/Fl 
mice had a significantly reduced brain weight at all three de-
velopmental stages investigated (postnatal day (P) 7, 14 and 
adulthood). As the mutant mice were phenotypically distinct 
from the used controls but still viable beyond sexual maturity, 
and because a homozygous TCF4 loss in adult mice has not 
been investigated yet, we decided to focus our analyses on 
hGFAP-cre::Tcf4Fl/Fl mice.
3.2 | Differentiation and 
migration of neuronal precursors are 
dependent on Tcf4 function
In order to study the functions of TCF4 during embryonic 
development, we analysed prenatal mouse brains. We com-
pared two embryonic stages: early after the start of the hG-
FAP-driven recombination activity at E14.5 and at E16.5. 
The comparison of the overall brain architecture (Figure 
2a1,b1,c1,d1) did not reveal any major differences between 
control and mutant littermates. We then focused our investi-
gations on two brain regions that are particularly important 
F I G U R E  1  Description of hGFAP-cre::Tcf4Fl/Fl mice. (a) Schematic drawing of the mouse model used in this study. Cre-mediated 
recombination of the DNA sequence between the loxP sites (red triangles) results in a truncated TCF4 protein without the essential bHLH domain 
(dark red). (b) Agarose gel images showing the results of a PCR targeting the floxed TCF4 gene and the recombined allele. Mice carrying only 
wild-type TCF4 allele show no band in the recombination PCR. (c) Whole-mount photographs of brains from control mice and mice with a 
heterozygous or homozygous loss of Tcf4. Arrows point towards the smaller cerebral hemispheres. Scale bar = 250 µm. (d) Fresh brain weights of 
hGFAP-cre, hGFAP-cre::Tcf4Fl/wt and hGFAP-cre::Tcf4Fl/Fl mice at different ages (n = 3 for P7, n = 8–15 for P14 and n = 3 for adult animals). 
*p < .05, ****p < .0001
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in cognition: the cerebral cortex and the hippocampus. In 
comparison to the intact overall brain morphology of control 
mice, we detected a differentiation and migration deficit in 
neural precursor cells of mice without functional TCF4.
At E14.5, no differences were detectable, neither in mor-
phology (Figure 2a2–a3/b2–b3) nor in the expression of 
PROX1, a marker for hippocampal granule cells (Figure 2a4/
b4), or SOX2 and CRE (as a surrogate for hGFAP), markers 
for neural stem cells (Figure 2a5/b5,a6/b6).
We also examined the germinal centre of the developing 
cortex, the ventricular zone (VZ), visualized by the expres-
sion of SOX2. At E14.5, we did not see a difference in the 
thickness of the VZ (Figure 2a7/b7). We neither observed a 
difference in the amount or location of proliferating (KI67+) 
cells (Figure 2a8/b8) nor regarding hGFAP-cre expressing 
stem cells (Figure 2a9/b9).
However, 2  days later in embryonic development, the 
control and the mutant mice became histologically distinct. 
In the control animals, the developing dentate gyrus with 
its PROX1-positive granular cells already had established 
its characteristic U-shape with the two blades of the den-
tate gyrus, whereas the PROX1-positive cells in the mu-
tant mice did not form this anatomic structure (Figure 2c4/
d4). The developing hippocampus was visibly smaller in 
hGFAP-cre::Tcf4Fl/Fl mice, whereas the adjacent germinal 
centre, the dentate neuroepithelium (DNE), was signifi-
cantly thicker (Figure 2c2,c5/d2,d5,f). In agreement with the 
thickened DNE, significantly fewer SOX2-positive neuronal 
precursor cells were detectable within the developing den-
tate gyrus (2ry and 3ry matrix) in the mutant animals com-
pared with healthy control mice (Figure 2c5/d5,g). These 
data suggest that the migration of neural precursor cells in 
the developing hippocampus from their germinal centre, the 
DNE, to their destination, the dentate gyrus, is disturbed in 
mice without a functional TCF4. Additionally, we evaluated 
the amount of further differentiated cells in the developing 
hippocampus, indicated by positivity of the neuronal marker 
NEUN. We observed that the number of NEUN-positive cells 
was significantly decreased in the mutant compared with the 
wild-type situation, in which cells of the developing dentate 
gyrus were differentiating and becoming NEUN-positive by 
E16.5 (Figure 2c6/d6,h).
We also studied the VZ as the germinal centre of the devel-
oping cortex for morphology and neural marker expression. 
The overall cortical architecture seemed to be intact indepen-
dent of functional TCF4 (Figure 2c3/d3), but the thickness 
of the VZ was affected by a TCF4 deletion. The VZ was 
identified by the expression of the neural stem cell marker 
SOX2, and the thickness was measured (Figure 2c7/d7,e). In 
control mice, the thickness of the VZ decreased from E14.5 
to E16.5. This decrease in VZ thickness was not detected in 
hGFAP-cre::Tcf4Fl/Fl mice, which results in a significantly 
thicker VZ at E16.5 in comparison to controls (Figure 2e).
When taking a closer look at the proliferation in the 
subventricular zone (SVZ) at E16.5, indicated by KI67-
positivity, we speculated about a higher rate of proliferation 
in mutant mice in comparison with control animals (Figure 
2c8/d8). However, quantification of KI67+ did not result in 
statistical significant differences (data not shown). Still, our 
finding support the notion that precursor cells in the mutant 
remain longer in their germinal centre and show a delayed 
differentiation compared with the control.
3.3 | TCF4 function is important 
for the differentiation of progenitor cells 
in the hippocampus and the hippocampal 
architecture
As one of the two neurogenic regions in the adult brain, the 
hippocampus is especially important for memory and cog-
nition. Therefore, we extended our investigation of the em-
bryonic development of hGFAP-cre::Tcf4Fl/Fl mice to an 
investigation of the postnatal hippocampus at three different 
postnatal developmental stages: newborn mice (P0), young 
mice (P7) and adult mice (P37). At all three analysed points 
in time, hGFAP-cre::Tcf4Fl/Fl mice were morphologically 
clearly distinguishable from the control animals. The entire 
hippocampus was visibly smaller, and the cellular architec-
ture was disturbed. This is visible in H&E stains (Figure 
3a1,a4/b1,b4;c1,c4/d1,d4;e1,e4/f1,f4) and in stains of the 
granule cell marker PROX1 (Figure 3a2/b2,c2/d2,e2/f2).
In line with the differentiation deficit that we observed 
at the embryonic stages, we also detected a delay in differ-
entiation in the postnatal hippocampus. In the hGFAP-cre 
animals, the cornu ammonis as well as the dentate gyrus of 
a newborn animal contained NEUN-positive cells (Figure 
3a3), and at P7, all granule cells of the hippocampus differ-
entiated into NEUN-positive neurons (Figure 3c3). In con-
trast, in the hGFAP-cre::Tcf4Fl/Fl mice, no NEUN-positive 
cells were detected at P0 (Figure 3b3). At P7, some cells 
have differentiated into NEUN-positive cells, which is 
comparable to the amount of NEUN-positive cells at P0 
in hGFAP-cre mice (Figure 3a3). At P37, all cells of the 
hippocampus in hGFAP-cre and in hGFAP-cre::Tcf4Fl/Fl 
mice were NEUN-positive (Figure 3e3/f3), thereby show-
ing a differentiation delay in TCF4-deficient cells but no 
differentiation failure.
The granular cells of the cornu ammonis were highly dis-
persed in the mutant, whereas a tight band of cells formed the 
stratum pyramidalis in control brains (Figure 3a4–a5,c4–c5/
b4–b5,d4–d5). This effect was more pronounced in the young 
animals, whereas in the adult, the cells were no longer widely 
dispersed throughout the entire cornu ammonis, but rather 
spots of dispersed cells throughout the stratum pyramidalis 
could be detected (Figure 3f7).
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We took a closer look at the dispersion of cells of the CA1 
region of the hippocampus and employed the granular cell 
marker CTIP2 and RELN as a marker for Cajal–Retzius cells 
and RELN-expressing interneurons of the hippocampus (Figure 
3a8–a9, c8–c9,e8–e9/b8–b9,d8–d9,f8–f9). Specific analysis 
revealed that in control animals, RELN-expressing interneu-
rons were evenly distributed throughout the stratum oriens of 
the CA1 region and CTIP2-positive granular cells formed the 
underlying stratum pyramidalis. In hGFAP-cre::Tcf4Fl/Fl mice, 
this layer structure was destroyed with up to 60% of misplaced 
RELN-expressing interneurons being located between CTIP2-
positive neurons (Figure 3g). Our results intensify speculations 
about the putative role of TCF4 in the differentiation process 
of neuronal precursor cells.
3.4 | Large fibre tracts are diminished in 
TCF4-deficient animals
As not only neurons but also other cell types of the develop-
ing brain are affected by the TCF4 deletion, we also analysed 
the corpus callosum as a large fibre tract in the mammalian 
brain (Figure 4). We investigated the myelination by em-
ploying the Klüver–Barrera (or Luxol fast blue) staining and 
the oligodendrocytes with the pan-oligodendrocyte marker 
Olig2. The CC develops postnatally, so that no difference of 
the overall morphology or myelination in the brain of new-
born mice of either genotype can be observed (Figure 4a/b). 
However, at P7, the CC is clearly visible in the control ani-
mal (Figure 4c1) although not completely myelinated (Figure 
4c2), whereas in the mutant, no CC is observable in the same 
sectioning plane (Figure 4d). In the adult animals, the CC 
developed also in the mutant animal (Figure 4f1), but is sig-
nificantly thinner (Figure 4g). The myelination is weaker in 
mutant animals (Figure 4e2/f2), and the percentage of Olig2-
positive oligodendrocytes is reduced in the TCF4-deficient 
animals (Figure 4e3/f3,h).
3.5 | The cortex layer structure and neuron 
morphology are affected by a TCF4 deletion, 
which is supported by the connection of TCF4 
signalling and neuron differentiation and 
development in gene expression analysis
Additionally, we investigated the cerebral cortex in order 
to reveal effects of a TCF4 deletion. The overall architec-
ture was preserved in mutant animals (Figure 5a1,c1,e1/
b1,d1,f1). Therefore, we examined the cortical layer struc-
ture by staining for the neuronal markers CTIP2 and CUX1. 
CTIP2 was expressed by neurons of the deeper layers V 
and VI (Arlotta et al., 2005), whereas CUX1 was expressed 
in the upper layers II, III and IV (Nieto et al., 2004). For 
comparing the thickness of deeper and upper layers be-
tween mice, the absolute thickness of the respective lay-
ers was measured and respective values of the control 
mice were defined as 100% thickness. Subsequently, the 
relative thickness of the deeper and upper layers of mutant 
mice was calculated. The deep layers V and VI of mutant 
mice did not seem to be affected by the deletion (Figure 
5a2,c2,e2/b2,d2,f2) and did not alter in thickness from the 
controls (data not shown), whereas the upper layers II/III 
were significantly thinner across all observed developmen-
tal stages in mutant mice (Figure 5a3,c3,e3/b3,d3,f3,g).
In order to gain more information about the underlying 
mechanisms of the ID in PTHS patients, we analysed the 
neuronal morphology of murine cortical neurons, which 
were stained by Golgi–Cox impregnation. We investigated 
the morphology of the pyramidal neurons of the cortical 
layer II and III (Figure 5h1). Abnormalities in neuronal 
morphology have been associated with different neurode-
velopmental and neurodegenerative diseases (reviewed for 
example in Dierssen & Ramakers, 2006). We observed a 
trend of a shorter apical dendrite in hGFAP-cre::Tcf4Fl/Fl 
mice (Figure 5h2) and a significant increase in the num-
ber of branches (Figure 5h3). The formation of the deep 
F I G U R E  2  TCF4 is important for embryonic development and differentiation. (a–b) Representative haematoxylin/eosin (H&E) stains and 
immunohistochemistry using antibodies against PROX1, SOX2, CRE and KI67 showing different brain regions of E14.5 hGFAP-cre and hGFAP-
cre::Tcf4Fl/Fl mice: the whole brain (a1/b1), the dorsal telencephalon (a2/b2, a4–a6/b4–b6) and the developing cortex (a3/b3, a7–a9/b7–b9). Arrows 
point towards the equal thickness of the VZ (a7/b7) and the similar number of proliferating cells above the VZ (a8/b8). CRE antibodies in a6, a9, 
b6 and b9 mark recombinase expression and serve as a surrogate marker for GFAP. (c–d) Representative H&E stains and immunohistochemistry 
using antibodies against PROX1, SOX2, CRE, NEUN and KI67 displaying different regions of the developing brain from E16.5 hGFAP-cre 
and hGFAP-cre::Tcf4Fl/Fl mice: the whole brain (c1/d1), the dorsal telencephalon (c2/d2, c4–c6/d4–d6) and the developing cortex (c3/d3, c7–c9/
d7–d9). PROX1+ granule neuron precursor cells, SOX2+ cells and NEUN+ cells of the hippocampus are depicted in c4/d4, c5/d5 and c6/d6, 
respectively. The ventricular zone, identified by SOX2-positivity, is significantly thinner in the mutant mice (c7/d7). Proliferating (KI67+) cells 
can be found within the subventricular zone (SVZ) of both control and mutant mice and do not differ significantly (c8/d8). CRE staining in c9 
and d9 indicates recombinase activity in the VZ. (e–f) Quantification of the thickness of the VZ (e) and the DNE (f) at E16.5. Both zones were 
identified by SOX2-positive cells (n = 3, two-tailed unpaired t test). (g) Total number of SOX2-positive cells in the area of 2ry and 3ry matrix 
of the developing hippocampus at E16.5 per slide (n = 3, two-tailed unpaired t test). (h) Total number of NEUN-positive cells in the 2ry and 3ry 
matrix of the developing hippocampus at E16.5 per slide (n = 3, two-tailed unpaired t test). HNE = hippocampal neuroepithelium, DNE = dentate 
neuroepithelium, CH = cortical hem, VZ = ventricular zone, SVZ = subventricular zone, scale bar in a1/b1 = 500 µm, in a2–a9/b2–b9 = 100 µm, 
in c1/d1 = 500 µm, and in c2–c9/d2–d9 = 100 µm. *p < .05; **p < .01; ***p < .001
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(a1) (a2) (a3) (b1) (b2) (b3)
(e1) (e2) (e3) (f1) (f2) (f3)
(c1) (c2) (c3) (d1) (d2) (d3)
(a4) (a5) (a6) (b4) (b5) (b6)
(c4) (c5) (c6) (d4) (d5) (d6)
(a7) (a8) (a9) (b7) (b8) (b9)
(e4) (e5) (e6) (f4) (f5) (f6)
(e7) (e8) (e9) (f7) (f8)
(g)
(f9)
(c7) (c8) (c9) (d7) (d8) (d9)
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cortical layers starts at embryonic day E10 (Angevine 
& Sidman, 1961), and therefore, 3  days before the used 
hGFAP promoter becomes active (Zhuo et al., 2001). Thus, 
we suspected the knockdown of TCF4 to not affect the deep 
cortical layers, as the greater part of neurons in these lay-
ers have been generated days before the knockdown. Still, 
analysis on mutant layer V pyramidal neurons showed the 
same tendency to shorter apical dendrites and a signifi-
cantly increased number of branches (data not shown).
Finally, we were interested in the consequences of a CNS-
specific TCF4 deletion regarding global gene expression and 
therefore performed RNA-sequencing (RNA-seq.) on the 
forebrains of newborn hGFAP-cre and hGFAP-cre::Tcf4Fl/
Fl mice. We employed three mice per genotype and included 
both sexes in our analysis. We identified 542 DEGs with an 
FDR (false discovery rate) smaller than 0.1 (Table S1) and 
thereby discriminated control and mutant samples (Figure 
5h1). When we subjected the identified DEG to a GO term 
enrichment analysis, we found an enrichment of genes asso-
ciated with neuron development, differentiation and function 
(Figure 5h2). This illustrated the importance of TCF4 in the 
correct development and maintenance of the nervous system, 
which is also demonstrated in the developing animal and in 
the analysed brain structures of cortex, corpus callosum and 
hippocampus.
4 |  DISCUSSION
We employed a conditional knockout mouse model that al-
lowed us  to investigate the function of TCF4 not only in 
mouse brain development but also in adult mice. We describe 
here a role for TCF4 in the differentiation of neural progeni-
tor cells, the establishment of proper cortical and hippocam-
pal architecture and neuron morphology.
Whereas it might seem counterintuitive to use a homo-
zygous knockout mouse model for TCF4 loss when PTHS 
is caused by a heterozygous mutation, we purposely decided 
to use the homozygous mice for different reasons. Firstly, 
heterozygous hGFAP-cre::Tcf4Fl/wt mice were indistinguish-
able from control animals in their brain morphology. This was 
unexpected to a certain extent, as for example mouse models 
with heterozygous Tcf4 loss described by Thaxton et al. showed 
reduced brain- and bodyweights in comparison with wild-type 
controls (Thaxton et al., 2018). Likely, this can be explained 
by the used promoters in their study that become active several 
days before the used hGFAP promoter in this study and thus 
affect a larger number of cell types during the developmental 
process (Mignone, Kukekov, Chiang, Steindler, & Enikolopov, 
2004; Shmerling et al., 2005). In addition, the weight measure-
ments in Thaxton et al. were performed on mice aged P70-90. 
This leaves room for speculations, as stronger effects on brain 
weights might also be observed in hGFAP-cre::Tcf4Fl/Fl mice 
at later stages. Secondly, our used CNS-specific deletion of 
TCF4 is exceptional as it circumvents the early postnatal le-
thality of conventional TCF4 knockout mouse models (Flora 
et al., 2007; Zhuang et al., 1996) and allows us to study the 
effects of a homozygous TCF4 loss in adult mice. Although 
genotypically different from the situation found in PTHS pa-
tients, we observe a distinct CNS phenotype with anatomical 
rearrangements not found in other Tcf4 mouse models, with-
out neglecting certain aspects of the human PTHS, such as the 
microcephaly, which affects 72% of all PTHS patients (Sweatt, 
2013). After all, none of the published mouse models for 
PTHS features all characteristics of the syndrome. Therefore, 
we suggest our hGFAP-cre::Tcf4Fl/Fl mice can be a convincing 
tool to investigate a homozygous Tcf4 loss in the CNS. It gives 
us the opportunity to study the affected structures in detail and 
to shed further light on the function of Tcf4 during CNS de-
velopment, helping us to understand the pathophysiology of 
PTHS eventually.
In order to study the effects of TCF4 on brain development 
and neuron differentiation further, we studied two embryonic 
stages of mouse development, E14.5 and E16.5. Based on the 
histological analysis of the embryonic brains of hGFAP-cre 
and hGFAP-cre::Tcf4Fl/Fl mice, we conclude that TCF4 is 
important for the correct differentiation of neuronal precur-
sor cells. The cells destined to build up the hippocampus and 
F I G U R E  3  Truncation of TCF4 leads to a developmental delay and a disturbance of the architecture in the postnatal hippocampus. (a–b) 
Representative haematoxylin/eosin (H&E) stains and immunohistochemistry using antibodies against PROX1, NEUN, CTIP2 and RELN of 
newborn hGFAP-cre and hGFAP-cre::Tcf4Fl/Fl mouse brains. Shown are sections through the whole brain (a1/b1), the hippocampus (a2–a6/b2–
b6) and the CA1 region (a7–a9/b7–b9). Arrows point towards the PROX1-positive granule cells of the developing DG (a2/b2), NEUN-positive 
differentiated cells in the hippocampus (a3/b3), the CTIP2-positive cells of the cornu ammonis (a5/b5) and RELN-positive interneurons in the 
CA1 region (a9/b9). (c–d) Representative H&E stains and immunohistochemistry using antibodies against PROX1, NEUN, CTIP2 and RELN of 
postnatal day 7 (P7) hGFAP-cre and hGFAP-cre::Tcf4Fl/Fl mouse brains: the whole brain (c1/d1), the hippocampus (c2–c6/d2–d6) and the CA1 
region (c7–c9/d7–d9). Arrows point towards PROX1-positive cells in the DG (c2/d2), NEUN-positive differentiated cells in the hippocampus (c3/
d3), CTIP2-positive cells of CA1 and DG (c5/d5) and RELN-positive interneurons of the CA1 region (c9/d9). (e–f) Representative H&E stains 
and immunohistochemistry using antibodies against PROX1, NEUN, CTIP2 and RELN of adult (P37) hGFAP-cre and hGFAP-cre::Tcf4Fl/Fl 
mouse brains: the whole brain (e1/f1), the hippocampus (e2–e6/f2–f6) and the CA1 region (e7–e9/f7–f9). Arrows point towards NEUN-positive 
differentiated cells in the hippocampus (e3/f3), CTIP2-positive granule cells of CA1 and DG (e5/e5) and RELN-positive interneurons in the 
CA1 region (e9/f9). (g) Quantification of RELN-positive cells in the hippocampus at P7 and P37. CA = cornu ammonis, DG = dentate gyrus, 
so = stratum oriens, sp = stratum pyramidalis. Scale bar in a1/b1/c1/d1/e1/f1 = 300 µm, in all other images = 100 µm
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cortex appear to remain longer in the germinal centres (DNE 
and VZ) and do not migrate out and differentiate properly.
Being mainly expressed during brain development (Jung 
et al., 2018; Rannals, Hamersky, et al., 2016a), numerous 
research groups have shed light upon different functions of 
TCF4 in this critical process. For example, in the SVZ, a zone 
of postnatal neurogenesis, TCF4 expression is described to 
be enriched and essential for the differentiation of progeni-
tor cells (Fischer et al., 2014). Furthermore, previous stud-
ies have suggested an association of TCF4 functions with 
neuronal development as well as differentiation and migra-
tion of cortical progenitors (Chen et al., 2016; Flora et al., 
2007; Forrest, Waite, Martin-Rendon, & Blake, 2013; Hill 
et al., 2017; Li et al., 2019; Page et al., 2018). One potential 
F I G U R E  4  The corpus callosum is severely disturbed by a loss of TCF4. (a–b) Representative haematoxylin/eosin (H&E) stains, Klüver–
Barrera stains, and immunohistochemistry using antibodies against OLIG2 of frontal newborn hGFAP-cre and hGFAP-cre::Tcf4Fl/Fl mouse brain 
slices. At this early age, no clear CC is visible neither in control, nor in mutant mice. (c–d) Representative haematoxylin/eosin (H&E) stains, 
Klüver–Barrera stains and immunohistochemistry using antibodies against OLIG2 of frontal 7 days old hGFAP-cre and hGFAP-cre::Tcf4Fl/
Fl mouse brain slices. As opposed to the control, no CC is visible in the same plane in TCF4-deficient mice at this age. (e–f) Representative 
haematoxylin/eosin (H&E) stains, Klüver–Barrera stains and immunohistochemistry using antibodies against OLIG2 of frontal adult hGFAP-cre 
and hGFAP-cre::Tcf4Fl/Fl mouse brain slices. Shown are overviews of the CC (e1–3/f1–3) and magnifications of the central CC (e4–6/f4–6). A 
dotted line marks the borders of the CC (e4–6/f4–6), which is distinctly thinner in the mutant. (g) The thickness of the CC, measured in H&E stains 
of adult animals, is significantly reduced in TCF4-deficient animals. (h) The percentage of OLIG2-positive cells per mm2 is decreased in mutant 
animals. CC = corpus callosum. Scale bar = 200 µm (a–d, e1–3, f1–3); 50 µm (e3–6/f3–6). *p < .05
(a1) (a2) (a3) (b1) (b2) (b3)
(c1) (c2) (c3) (d1) (d2) (d3)
(e1) (e2) (e3) (f1) (f2) (f3)
(e4) (e5)
(g) (h)
(e6) (f4) (f5) (f6)
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F I G U R E  5  Truncation of TCF4 results in cortical layer abnormalities and defects in neuronal morphology and affects genes responsible for 
differentiation and maturation. (a–f) Representative H&E stains and immunohistochemistry using antibodies against CTIP2 and CUX1 of newborn 
(a1–a3/b1–b3), seven-day-old (c1–c3/d1–d3) and adult (e1–e3/f1–f3) hGFAP-cre and hGFAP-cre::Tcf4Fl/Fl mouse brains. Arrows point towards 
the thickness of the CUX1-positive neurons of the cortical layers II and III (a2/b2, c2/d2, e2/f2). (g) Quantification of layer II/III thickness: absolute 
layer thickness of the CUX1 positive cortical layer II/II was measured across all three age stages. Layer thickness of control mice was defined as 
100%, and the relative layer thickness of mutant mice was calculated. Compared to the wild-type control, hGFAP-cre::Tcf4Fl/Fl mice showed a 
significant reduction in layer II/III thickness (n = 5). (h) Representative images of Golgi–Cox impregnated layer II/III neurons of adult hGFAP-
cre and hGFAP-cre::Tcf4Fl/Fl mouse brains. Arrows point towards the dendrite length and branches of the apical dendrite (h1). Measurement of 
the length of apical dendrites (h2) and number of branches of the apical dendrite (h3) of hGFAP-cre and hGFAP-cre::Tcf4Fl/Fl mice. n = 3, 40 
neurons per mouse. (i) Analysis of differential gene expression in the forebrain of newborn hGFAP-cre and hGFAP-cre::Tcf4Fl/Fl mice via RNA-
sequencing. In total, 542 DEGs with a false discovery rate of <0.1 were identified. The differential expression of genes discriminates control and 
mutant mice (i1). GO term enrichment correlates Tcf4 with neuron differentiation and development (i2). Scale bar = 100 µm. *p < .05
(a1) (a2) (a3) (b1) (b2) (b3)
(c1) (c2) (c3) (d1) (d2) (d3)
(e1) (e2) (e3) (f1) (f2) (f3)
(g)
(i1) (i2)
(h1) (h2) (h3)
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mechanism how TCF4 regulates differentiation is the associ-
ation with other TFs (Flora et al., 2007). Other investigations 
on TCF4 conclusively showed that TCF4 is crucial for the 
correct neuronal migration in the developing cortex and that 
a knockout of TCF4 causes a differentiation delay (Li et al., 
2019; Page et al., 2018). By using conventional heterozygous 
and homozygous knockout mouse models, the effects of a 
homozygous deletion were so far only studied embryonically 
and in early postnatal animals. Hence, our observations in 
adult mice carrying a CNS-specific homozygous deletion in 
the Tcf4 gene further complement the understanding of TCF4 
function. In summary, our results are in line with previous 
evidence and support the hypothesis that TCF4 is important 
for neuronal differentiation and that a differentiation deficit is 
a part of the pathobiology of PTHS.
When we analysed the postnatal hippocampus of hG-
FAP-cre::Tcf4Fl/Fl mice, we noticed that it resembles aspects 
of the well-characterized Reeler mouse. The Reeler mouse 
was first described in 1951 (Falconer, 1951) as a sponta-
neous mutant with severe neurological deficits and RELN 
was identified as the causing protein in 1995 (D'Arcangelo et 
al., 1995; Ogawa et al., 1995). These mice have a disrupted 
laminar organization of the cortex, a disturbed hippocampal 
architecture and a hypoplastic cerebellum (Fatemi, 2001). 
Mice with mutations in other members of the Reelin signal-
ling pathway such as DAB1 show similar phenotypes (for 
example: Kojima, Nakajima, & Mikoshiba, 2000; Sheldon et 
al., 1997). Mutations in the human RELN gene are  an un-
derlying cause of  lissencephaly (Chang et al., 2007) and, 
additionally, RELN mutations are associated with schizo-
phrenia, mood disorders, autism, polymicrogyria, epilepsy 
and Alzheimer's disease (reviewed for example in Ishii, 
Kubo, & Nakajima, 2016). The study of RELN-expressing 
cells in our mouse model revealed no obvious reduction in 
their number, but a misplacement of RELN-expressing in-
terneurons of the CA1 region (Figure 3a9,c9,e9/b9,d9,f9,g). 
As Reelin signalling is important for correct migration of 
neuronal precursor cells in the cortex and the hippocampus 
(Katsuyama & Terashima, 2009), it is feasible to speculate 
if the described misplacement of RELN-expressing cells is 
the underlying cause of the granular cell dispersion in our 
mouse model. The TFs converting the Reln signal into gene 
expression are not fully known. The serum response factor 
(SRF) was identified as a downstream target of Reelin sig-
nalling, and both the hippocampus of SRF-depleted mice 
and our TCF4 mutant mice show similar characteristics: a 
generally smaller hippocampus and dispersed granular cells 
with RELN-expressing interneurons within the granular cell 
layer of the stratum pyramidalis (Stritt & Knöll, 2010). This 
similarity raises the question if TCF4, like SRF, might be a 
downstream target of RELN. That TCF4 function might be 
crucial for several genes preferentially expressed by neurons 
of the hippocampal CA1 region was proposed before (Xia et 
al., 2018). A possible connection between the expression of 
TCF4 and its interaction with Reelin signalling can be estab-
lished via NOTCH1, whose expression has been shown to 
be affected by altered TCF4 expression in different in vitro 
experiments (Forrest et al., 2013; Xia et al., 2018). In turn, 
NOTCH1 itself interacts with Reelin signalling (Hashimoto-
Torii et al., 2008). Also, analysis of publicly available RNA-
seq data from Li et al. illustrates that both heterozygous and 
homozygous Tcf4 knockout mice show a certain modification 
in reelin signalling (Figure S1). Certainly, this proposition 
requires further investigations, but if a link between RELN 
and TCF4 signalling was established, it might help to further 
understand the molecular mechanisms underlying the pathol-
ogy of the PTHS.
In addition to the hippocampus, we analysed the neocortex 
of TCF4-deficient animals. We noted a thinning of the upper 
layers (CUX1+), whereas the deeper layers (CTIP2+) remain 
unimpaired by the deletion (Figure 4). These observations fit to 
the results described by Li et al. Their described conventional 
homozygous TCF4 knockout mouse models show hardly any 
CUX1-expressing cells in the upper layer of the neocortex ex-
cept for regions of the frontal/motor cortex (Li et al., 2019). 
The differences in the effects on the different layers in our 
model might also at least be partly explained by the promoter 
activity of the hGFAP promoter. It is known that the promoter, 
and thereby the recombination mediated by CRE, becomes 
active around E13 (Zhuo et al., 2001). The generation of cor-
tical neurons in the mouse starts around E10.5 (Hanashima 
& Toma, 2015), and consequently, early generated neurons, 
which build up the deeper layers V and VI, might not be as 
strongly affected by the Cre-driven deletion of TCF4.
We hypothesized before that TCF4 might be linked to 
RELN signalling and thereby affects the hippocampal archi-
tecture. We have described similarities between the phenotype 
of Reeler and hGFAP-cre::Tcf4Fl/Fl mice and a misplacement 
of RELN-expressing cells, which might be causing the gran-
ular cell dispersion in the hippocampus. In the cortex, the sit-
uation seems to be different. Whereas the cortical structure 
in the Reeler mice is completely disrupted (Fatemi, 2001), 
the cortex of hGFAP-cre::Tcf4Fl/Fl mice is intact, except for a 
thinning of the upper layers. Possible explanations for those 
observed differences between cortex and hippocampus might 
be an independence of RELN signalling from TCF4 in the 
cortex or the different developmental time points these struc-
tures start to develop. The cortical layer structure is estab-
lished from E10.5 onwards by the migration of Cajal–Retzius 
cells to the area, which becomes the cortical layer I later in 
development (Hanashima & Toma, 2015). These cells secrete 
RELN and thereby organize the inside-out migration of corti-
cal neurons. The hippocampus development, in comparison, 
only starts at E12.5 with the migration of Cajal–Retzius cells 
to the presumptive DNE (reviewed in Urbán & Guillemot, 
2014). It seems obvious to argue that the hippocampus 
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development might be more severely affected as the expres-
sion of the Cre recombinase, and thus the loss of functional 
TCF4 starts early enough to interfere with early hippocampal, 
but not cortical development. Still, it is important to consider 
that the layering of the cortex might be at least partially inde-
pendent of the presence of Cajal–Retzius cells in the layer I of 
the cortex (Yoshida, Assimacopoulos, Jones, & Grove, 2006). 
Certainly, these discrepancies need to be investigated in fu-
ture studies. Apart from this, taking into account the complex-
ity of the hippocampal architecture, it is reasonable to suspect 
numerous TFs to be needed to orchestrate the assembly of the 
hippocampus and that a loss of only one of those TFs, like 
TCF4, could hamper proper Reelin signalling, leading to the 
observed misconstruction of the hippocampus.
The CC is a major fibre tract in the mammalian brain, 
connecting both hemispheres. Abnormalities of the CC are 
associated with intellectual disability, autism and schizophre-
nia (reviewed for example in Paul et al., 2007). Furthermore, 
hypoplasia of the CC is a common clinical feature of PTHS 
patients (Marangi et al., 2012), and this is also reflected by 
our mouse model, which shows a delayed development of the 
CC and a reduced size (Figure 4). Additional to the reduced 
overall size of the CC, the percentage of Olig2-positive oligo-
dendrocytes is reduced in animals without functional TCF4. 
Obviously, a reduced amount of oligodendrocytes is associ-
ated with a reduced myelination and differentiation of the CC, 
and this is in line with the differentiation delay observed in 
the other brain structures and the overall developmental delay 
in PTHS patients. This is in line with results from Kennedy et 
al., as their heterozygous Tcf4 knockout mouse model shows 
a significant downregulation of numerous genes associated 
with myelination (Kennedy et al., 2016).
We were able to generate in vivo data of postmitotic 
neurons in adult homozygous knockout mice. This com-
plements findings regarding the impact of TCF4 on neuron 
function and morphology previously generated by others. It 
has been shown before that TCF4 is important for the ex-
citability and the long-term potentiation of neurons (Jung et 
al., 2018; Rannals, Hamersky, et al., 2016a). Additionally, 
it was demonstrated that TCF4 is also able to regulate den-
dritic spine density and spine morphology (Crux, Herms, 
& Dorostkar, 2018). It is believed that a disturbed neuro-
nal morphology is a common feature in ID and might cause 
cognitive impairments (reviewed for example in Dierssen & 
Ramakers, 2006). The effect of TCF4 on dendritic branching 
has been described in 2016 by D`Rozario et al., who pro-
posed that TCF4 restricts neurite branching at least partly 
through the repression of Neurexin. They showed that upon 
TCF4 knockout in postmitotic neurons, the number of den-
dritic branches is significantly increased, whereas the length 
of the longest dendrite (corresponding to the apical dendrite) 
is not altered (D'Rozario et al., 2016). Our in vivo data from 
hGFAP-cre::Tcf4Fl/Fl mice are in line with their observations 
despite using a different model. Li et al. analysed neuronal 
morphology in a heterozygous conventional knockout mouse 
model and observed an increased apical dendrite length and 
a reduced dendritic branching (Li et al., 2019). Although 
their results seem to contradict the observations made in our 
mouse model, together our data support the notion that TCF4 
is able to shape neuron morphology and thereby influences 
neuron function. Therefore, we hypothesize that a distur-
bance of neuronal morphology is an important factor in the 
development of ID in PTHS patients.
The effect of TCF4 signalling on neuronal morphology 
and differentiation is also reflected in our global gene expres-
sion analysis of the forebrains of newborn mice. In total, 542 
DEGs with an FDR < 0.1 were identified by RNA-sequencing 
which also shows the global effects of a TCF4 deletion. The 
GO term enrichment of the DEGs shows that especially genes 
involved in neuron differentiation and dendrite development 
are affected by the TCF4 deletion, which fits to the observed 
phenotypical abnormalities. In the past years, there have been 
several different studies trying to unravel the complex network 
of genes regulated by TCF4. Matching our data, differences 
in the expression of genes associated with axon/neuronal 
development (Xia et al., 2018), axon guidance (Doostparast 
Torshizi et al., 2019), neuronal differentiation (Quevedo et al., 
2019) and growth (Doostparast Torshizi et al., 2019) have been 
described following TCF4 knockdown in vitro. Other studies 
have reported that TCF4 knockdown in vitro rather leads to a 
differential expression of genes mainly involved in cell cycle 
regulation and apoptosis (Hill et al., 2017; Moen et al., 2017), 
especially in the context of the putative tumour-suppressive 
role of TCF4 in cancer development (Hellwig et al., 2019; 
Herbst, Helferich, Behrens, Goke, & Kolligs, 2009). This 
might seem incompatible with the other studies. However, 
many of the genes found to be altered are not only associated 
with cell cycling, but also with schizophrenia (Hill et al., 2017; 
Moen et al., 2017). Adding to this, there have been in vivo 
studies describing severe differences in gene expression fol-
lowing heterozygous and also homozygous knockout of Tcf4 
in mice. In line with our results, conventional heterozygous 
Tcf4 knockdown resulted mainly in dysregulation of biochem-
ical pathways linked to neuronal plasticity, axon guidance and 
neurogenesis (Kennedy et al., 2016). Beyond that, analysis of 
newborn homozygous Tcf4 knockout mice revealed a criti-
cal downregulation of genes involved in synapse and neuron 
formation as well as neurite outgrowth further supporting 
an involvement of TCF4 in these processes (Li et al., 2019). 
Additionally, they demonstrate that a deletion of TCF4 results 
in a shift towards a more immature gene signature (Li et al., 
2019). The results from our own global gene expression anal-
ysis and from the data generated by others are in line with the 
here described histologically observed differentiation delay in 
hippocampus, corpus callosum and cortex and the abnormali-
ties in neuron morphology.
14 |   SCHOOF et al.
Together, the data from the different developmental stages 
and the global gene expression data strongly suggest that TCF4 
is important for the correct development and differentiation of 
the nervous system including neurons and other cell types like 
oligodendrocytes. The understanding of the global function of 
TCF4 and the analysis of different aspects like the disturbances 
in hippocampal architecture and the abnormalities of dendrite 
morphology and CC hypoplasia might help to understand the 
mechanisms underlying the ID of PTHS patients. We believe 
that our results add to a full understanding of the role of TCF4 
in brain development in general. The unveiling of such mo-
lecular mechanisms leading to the clinical presentation of the 
PTHS will help us to understand the disorder properly, improve 
the life of patients, pave the way for future studies and lead to 
the development of therapeutic agents eventually.
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